These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12077822)

  • 1. [Role of physico-chemical and biochemical composition of urine in the genesis of combined nephrolithiasis and cholelithiasis].
    Neĭmark AI; Fidirkin AV; Savenko VI
    Urologiia; 2002; (2):37-40. PubMed ID: 12077822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urinary magnesium excretion in nephrolithiasis].
    Simeonov S; Dimitrakova D; Kumchev E
    Vutr Boles; 1988; 27(6):39-43. PubMed ID: 3247702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors increasing the risk for stone formation in adult patients with cystic fibrosis.
    Terribile M; Capuano M; Cangiano G; Carnovale V; Ferrara P; Petrarulo M; Marangella M
    Nephrol Dial Transplant; 2006 Jul; 21(7):1870-5. PubMed ID: 16595587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body size and 24-hour urine composition.
    Taylor EN; Curhan GC
    Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The change of human Na+/dicarboxylate co-transporter 1 expression in the kidney and its relationship with pathogenesis of nephrolithiasis].
    He Y; Chen X; Yu Z
    Zhonghua Yi Xue Za Zhi; 2001 Sep; 81(17):1066-9. PubMed ID: 11758258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Laboratory methods of predicting primary and recurrent nephrolithiasis].
    Alchinbaev MK; Malik AM; Merkusheva NV; Makhonina IA
    Urologiia; 2000; (5):9-10. PubMed ID: 11392229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of urine sodium on urine risk factors for calcium oxalate nephrolithiasis.
    Eisner BH; Eisenberg ML; Stoller ML
    J Urol; 2009 Nov; 182(5):2330-3. PubMed ID: 19758639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis.
    Cameron MA; Maalouf NM; Adams-Huet B; Moe OW; Sakhaee K
    J Am Soc Nephrol; 2006 May; 17(5):1422-8. PubMed ID: 16597681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers.
    Massey LK; Sutton RA
    J Urol; 2004 Aug; 172(2):555-8. PubMed ID: 15247728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does a high concentration of calcium in the urine cause an important renal concentrating defect in human subjects?
    Lam GS; Asplin JR; Halperin ML
    Clin Sci (Lond); 2000 Mar; 98(3):313-9. PubMed ID: 10677390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation.
    Penniston KL; Steele TH; Nakada SY
    Urology; 2007 Nov; 70(5):856-60. PubMed ID: 17919696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary oxalate and calcium oxalate nephrolithiasis.
    Khan SR; Glenton PA; Byer KJ
    J Urol; 2007 Nov; 178(5):2191-6. PubMed ID: 17870111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
    Nelson WK; Houghton SG; Milliner DS; Lieske JC; Sarr MG
    Surg Obes Relat Dis; 2005; 1(5):481-5. PubMed ID: 16925274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium dicarboxylate cotransporter-1 expression in renal tissues and its role in rat experimental nephrolithiasis.
    He Y; Chen X; Yu Z; Wu D; Lv Y; Shi S; Zhu H
    J Nephrol; 2004; 17(1):34-42. PubMed ID: 15151257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of fasting hypercalciuria associated with increased citraturia in the ambulatory evaluation of nephrolithiasis.
    Damasio B; Massarino F; Durand F; Banchero R; Bottino P; De Franchis V; Carmignani G; Cannella G
    J Nephrol; 2005; 18(3):262-6. PubMed ID: 16013013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in urine volume accomplished by physicians treating nephrolithiasis.
    Parks JH; Goldfischer ER; Coe FL
    J Urol; 2003 Mar; 169(3):863-6. PubMed ID: 12576800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic abnormalities associated with calyceal diverticular stones.
    Auge BK; Maloney ME; Mathias BJ; Pietrow PK; Preminger GM
    BJU Int; 2006 May; 97(5):1053-6. PubMed ID: 16643491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.